German healthcare group, Merck, has re-launched its Type 2 diabetes drugs, Glucovance and Glucophage, to effectively tackle the ailment in the country.
Clarkson Voke Eberu
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business